Reply: Is Pathology Always the Diagnostic Gold Standard in Neurodegeneration?-Reference-Cited by-同舟云学术

Reply: Is Pathology Always the Diagnostic Gold Standard in Neurodegeneration?

Published:2022-10-03 Issue:8 Volume:9 Page:1154-1155
ISSN:2330-1619
Container-title:Movement Disorders Clinical Practice
language:en
Short-container-title:Movement Disord Clin Pract

Author:

Ryan Stephen A.¹²,Masellis Mario¹³,Bilbao Juan⁴,Keith Julia⁴,Rogaeva Ekaterina⁵,Black Sandra E.¹³⁶,Lang Anthony E.³⁷,Kleiner Galit³⁸

Affiliation:

1. L.C. Campbell Cognitive Neurology Research Unit Sunnybrook Health Sciences Centre Toronto Ontario Canada

2. Division of Neurology, Department of Medicine Queens University Kingston Ontario Canada

3. Division of Neurology, Department of Medicine University of Toronto Toronto Ontario Canada

4. Department of Laboratory Medicine and Molecular Diagnostics, Sunnybrook Health Sciences Centre, Laboratory Medicine and Pathobiology University of Toronto Toronto Ontario Canada

5. Tanz Centre for Research in Neurodegenerative Disease University of Toronto Toronto Ontario Canada

6. Hurvitz Brain Sciences Program, Sunnybrook Research Institute Toronto Ontario Canada

7. Edmond J Safra Program in Parkinson's Disease and the Morton and Gloria Shulman Movement Disorders Clinic, Toronto Western Hospital University Health Network Toronto Ontario Canada

8. Baycrest Centre for Geriatric Care Toronto Ontario Canada

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/mdc3.13571

Reference6 articles.

1. Is Pathology Always the Diagnostic Gold Standard in Neurodegeneration?

2. Neither a Novel Tau Proteinopathy nor an Expansion of a Phenotype: Reappraising Clinicopathology-Based Nosology

3. Case of a Man with Hemichorea and Behavioral Changes: “A Red Herring”

4. Neuropathological criteria of anti-IgLON5-related tauopathy